Roche MagNAPure

The Florida Department of Health, Bureau of Public Health Laboratories is seeking to procure a nucleic acid extraction instrument, specifically the Roche MagNA Pure 24, along with subsequent annual service agreements. The instrument must be validated and approved by the Centers for Disease Control and Prevention for public health emergency preparedness activities, including pandemic influenza and Laboratory Response Network methods for detecting bioterrorism threat agents and emerging infectious diseases. The Department requires an instrument that can extract up to 24 samples at a time with a short turnaround time to provide results quickly, which aligns with the performance measures set by the Public Health Laboratory Response Network. The Department is requesting authorization to purchase 1 MagNA Pure 24 laboratory instrument and related service agreements as a single source from Roche Diagnostics Corporation, the exclusive manufacturer, distributor, and service provider of this instrument. The estimated dollar amount for this purchase is $242,000.00.

This procurement is restricted to Roche Diagnostics Corporation as the sole source due to the specific technical requirements and the Department's determination that these commodities or services are only available from this single source. There are no set-aside designations or restrictions on the types of organizations that can respond. The current Roche MagNA Pure LC 2.0 and MagNA Pure Compact instruments used by the Department are being replaced by the new MagNA Pure 24 instrument. The procurement process includes a due date of December 15, 2022 for responses.